HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Luigi Rocco Chiri Selected Research

Polytetrafluoroethylene (Teflon)

2/2022Subjective experience of aberrant salience in young people at Ultra-High Risk (UHR) for psychosis: a cross-sectional study.
1/2022Aberrant salience in first-episode psychosis: Longitudinal stability and treatment-response.
12/2021Overcoming the gap between child and adult mental health services: The Reggio Emilia experience in an early intervention in psychosis program.
12/2021Negative symptom dimensions in first episode psychosis: Is there a difference between schizophrenia and non-schizophrenia spectrum disorders?
2/2021Subjective experience of social cognition in young people at Ultra-High Risk of psychosis: a 2-year longitudinal study.
1/2021Suicidal thinking and behaviours in First Episode Psychosis: Findings from a 3-year longitudinal study.
1/2021Anhedonia in the Psychosis Risk Syndrome: State and Trait Characteristics.
12/2020Subjective experience of social cognition in adolescents at ultra-high risk of psychosis: findings from a 24-month follow-up study.
8/2020Anhedonia in young people with first episode psychosis: a longitudinal study.
1/2020Suicide risk in young people at Ultra-High Risk (UHR) of psychosis: Findings from a 2-year longitudinal study.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Luigi Rocco Chiri Research Topics

Disease

15Psychotic Disorders (Schizoaffective Disorder)
02/2022 - 06/2018
2Anhedonia
01/2021 - 08/2020
1Schizophrenia (Dementia Praecox)
12/2021
1Aphasia (Dysphasia)
12/2021
1Mental Disorders (Mental Disorder)
01/2020
1Substance-Related Disorders (Drug Abuse)
11/2019

Drug/Important Bio-Agent (IBA)

15Polytetrafluoroethylene (Teflon)FDA Link
02/2022 - 06/2018
22-bromolysergic acid diethylamide (BOL)IBA
01/2021 - 08/2020
1Silver Sulfadiazine (SSD)FDA LinkGeneric
12/2021
1SolutionsIBA
12/2021

Therapy/Procedure

1CARE protocol
12/2021